...
首页> 外文期刊>Analytical chemistry >Faster Protocol for Endogenous Fatty Acid Esters of Hydroxy Fatty Acid (FAHFA) Measurements
【24h】

Faster Protocol for Endogenous Fatty Acid Esters of Hydroxy Fatty Acid (FAHFA) Measurements

机译:羟基脂肪酸内源性脂肪酸酯的更快方案(FAHFA)测量

获取原文
获取原文并翻译 | 示例
           

摘要

Fatty acid esters of hydroxy fatty acids (FAHFAs) are a recently discovered class of endogenous lipids with antidiabetic and anti-inflammatory activities. Interest in these lipids is due to their unique biological activites and the observation that insulin-resistant people have lower palmitic acid esters of hydroxystearic acid (PAHSA) levels, suggesting that a FAHFA deficiency may contribute to metabolic disease. Rigorous testing of this hypothesis will require the measurement of many clinical samples; however, current analytical workflows are too slow to enable samples to be analyzed quickly. Here we describe the development of a significantly faster workflow to measure FAHFAs that optimizes the fractionation and chromatography of these lipids. We can measure FAHFAs in 30 min with this new protocol versus 90 min using the older protocol with comparable performance in regioisomer detection and quantitation. We also discovered through this optimization that oleic acid esters of hydroxystearic acids (OAHSAs), another family of FAHFAs, have a much lower background signal than PAHSAs, which makes them easier to measure. Our faster workflow was able to quantify changes in PAHSAs and OAHSAs in mouse tissues and human plasma, highlighting the potential of this protocol for basic and clinical applications.
机译:羟基脂肪酸(Fahfas)的脂肪酸酯是最近发现的抗糖尿病和抗炎活动的内源性脂质。对这些脂质的兴趣是由于它们独特的生物活化,并且观察到胰岛素抗性人对羟半酸(PAHSA)水平的较低棕榈酸酯,表明FAHFA缺乏可能导致代谢疾病。对该假设的严格测试需要测量许多临床样本;但是,目前的分析工作流程太慢,以便快速分析样品。在这里,我们描述了一个明显更快的工作流程的发展,以测量优化这些脂质的分馏和色谱的FahFA。我们可以在30分钟内测量FAHFA,并使用较旧的协议与90分钟,使用较旧的协议具有相当的性能,可在Regioisomer检测和定量中进行相当的性能。我们还通过这种优化发现,羟基酸的油酸酯(Oahsas),另一家Fahfas系列,比Pahsas更低的背景信号,使它们更容易测量。我们更快的工作流程能够在小鼠组织和人体血浆中量化Pahsas和Oahsas的变化,突出了该方案的基本和临床应用的潜力。

著录项

  • 来源
    《Analytical chemistry》 |2018年第8期|共8页
  • 作者单位

    Salk Inst Biol Studies Clayton Fdn Labs Peptide Biol 10010 North Torrey Pines Rd La Jolla CA 92037 USA;

    Univ Calif San Diego Skaggs Sch Pharm &

    Pharmaceut Sci 9500 Gilman Dr La Jolla CA 92093 USA;

    Salk Inst Biol Studies Clayton Fdn Labs Peptide Biol 10010 North Torrey Pines Rd La Jolla CA 92037 USA;

    Salk Inst Biol Studies Clayton Fdn Labs Peptide Biol 10010 North Torrey Pines Rd La Jolla CA 92037 USA;

    Univ Calif San Diego Skaggs Sch Pharm &

    Pharmaceut Sci 9500 Gilman Dr La Jolla CA 92093 USA;

    Lund Univ Div Expt Vasc Res Dept Clin Sci S-22100 Lund Sweden;

    Harrod Res Frans Persons Vag 6 S-40229 Gothenburg Sweden;

    Harvard Med Sch Beth Israel Deaconess Med Ctr Dept Med Div Endocrinol Diabet &

    Metab Boston MA 02215 USA;

    Univ Calif San Diego Skaggs Sch Pharm &

    Pharmaceut Sci 9500 Gilman Dr La Jolla CA 92093 USA;

    Salk Inst Biol Studies Clayton Fdn Labs Peptide Biol 10010 North Torrey Pines Rd La Jolla CA 92037 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号